Camelot Portfolios’s MetLife MET Stock Holding History

Camelot Portfolios’s Portfolio MET Stock Details MET Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-45	Closed	-$3.55K	–	390
2025 Q4	$3.55K	Buy	+45	New	+$3.56K	﹤0.01%	506
2024 Q3	–	Sell	-45	Closed	-$3.16K	–	382
2024 Q2	$3.16K	Buy	+45	New	+$3.21K	﹤0.01%	502

Other funds holding MET

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Camelot Portfolios's MET Position: Q1 2026 in Review

Camelot Portfolios sold out of MetLife (MET) in Q1 2026, closing a stake of 45 shares — an estimated $3.55K sold.

Camelot Portfolios first reported a position in MET in Q2 2024 and held it in 2 quarters. The position peaked at $3.55K in Q4 2025. 1,384 funds tracked by Wall St. Rank hold MET as of Q1 2026.

Camelot Portfolios reported no remaining MetLife position as of Q1 2026 after selling out during the quarter.
Camelot Portfolios sold 45 MetLife shares in Q1 2026, an estimated $3.55K.
Camelot Portfolios first reported a position in MetLife in Q2 2024 and held it in 2 quarters.
Camelot Portfolios's MetLife position peaked at $3.55K in Q4 2025.
1,384 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Camelot Portfolios's 13F filing for Q1 2026, filed 8 May 2026.